RXFP1 and cancer: These migratory effects were associated with chemotaxis toward MCP-1, a chemokine critical for recruiting leukocytes to sites of inflammation or cancer, and were shown to depend on the RXFP1/Gαs/adenylate cyclase/cAMP signaling axis [84,89].